Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How apoptosis is regulated, and what goes wrong in cancer

23 Jun 2001

Abstract excerpt

ABSTRACT A new betacoronavirus named SARS-CoV-2 has emerged as a new threat to global health and economy. A promising target for both diagnosis and therapeutics treatments of the new disease named COVID-19 is the coronavirus (CoV) spike (S) glycoprotein. By constant-pH Monte Carlo simulations and the PROCEEDpKa method, we have mapped the electrostatic epitopes for four monoclonal antibodies and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Cell death mechanisms and regulation
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11420280
DOI: 10.1136/bmj.322.7301.1538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How apoptosis is regulated, and what goes wrong in cancerPMID 11420280Read ↗

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies.Semantic proximity Read ↗

Up State of the SARS-COV-2 Spike Homotrimer Favors an Increased Virulence for New VariantsSemantic proximity Read ↗

The Up state of the SARS-COV-2 Spike homotrimer favors an increased virulence for new variantsSemantic proximity Read ↗

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studiesSemantic proximity Read ↗

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulationSemantic proximity Read ↗

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.Semantic proximity Read ↗

Accurate Evaluation on the Interactions of SARS-CoV-2 with Its Receptor ACE2 and Antibodies CR3022/CB6*Semantic proximity Read ↗

The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2.Semantic proximity Read ↗

SARS-CoV-2 variants infectivity prediction and therapeutic peptide design using computational approaches.Semantic proximity Read ↗

DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.Semantic proximity Read ↗

A new proposed mechanism of some known drugs targeting the SARS-CoV-2 spike glycoprotein using molecular dockingSemantic proximity Read ↗

Modified Intelligent Magnetic Nano particles as A Treatment for SARS Corona Virus Type 2 In SilicoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.